Five things to know:
1. The neuroscience business saw fourth quarter revenue of $2.3 billion, unchanged from the same time last year. For the entire 2022 fiscal year, revenue was $8.8 billion, a 7 percent increase from last year.
2. Cranial and spinal technologies in the fourth quarter saw a 2 percent decrease in sales year over year with $1.2 billion.
3. Fourth quarter revenue of $8.1 billion was a 1 percent decrease year over year.
4. Total revenue in fiscal year 2022 grew 5 percent compared to fiscal year 2021.
5. Medtronic’s quarterly dividend increased 8 percent year over year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
